Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells

Journal of Surgical Research

Volumn 199, Issue 1, 2015, Pages 266-273

  Bools, Lindsay M ^a   Fisher, Richard K ^a   Grandas, Oscar H ^a   Kirkpatrick, Stacy S ^a   Arnold, Joshua D ^a   Goldman, Mitchell H ^a   Freeman, Michael B ^a   Mountain, Deidra J H ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

Author keywords

Gene therapy; Poly(B amino ester)s; Polyethylenimine; Polymeric transfection; siRNA; Vascular smooth muscle cells

Indexed keywords

ESTER; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; POLY (B AMINO ESTER); POLYETHYLENEIMINE; POLYMER; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; GENETIC MARKER; POLY(BETA-AMINO ESTER);

ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASCULAR SMOOTH MUSCLE CELL; VASCULAR TISSUE; AORTA; CYTOLOGY; EVALUATION STUDY; GENETIC MARKER; GENETICS; IN VITRO STUDY; PROCEDURES; VASCULAR SMOOTH MUSCLE;

AORTA; GENE SILENCING; GENETIC MARKERS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; IN VITRO TECHNIQUES; MUSCLE, SMOOTH, VASCULAR; POLYETHYLENEIMINE; POLYMERS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84944162297     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.07.025     Document Type: Article

References (26)

1. R.S. Dieter, and J. Laird Overview of restenosis in peripheral arterial interventions Endovasc Today 3 2004 36
2. R. Fattori, and T. Piva Drug-eluting stents in vascular intervention The Lancet 361 2003 247
3. T.M. Schiele, F. Krotz, and V. Klauss Vascular restenosis - striving for therapy Expert Opin Pharmacother 5 2004 2221
4. G. Dangas, and F. Kuepper Cardiology patient page. Restenosis: repeat narrowing of a coronary artery: prevention and treatment Circulation 105 2002 2586
5. O.H. Grandas, D.H. Mountain, S.S. Kirkpatrick, and et al. Regulation of vascular smooth muscle cell expression and function of matrix metalloproteinases is mediated by estrogen and progesterone exposure J Vasc Surg 49 2009 185
6. O.H. Grandas, D.J. Mountain, S.S. Kirkpatrick, and et al. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells J Surg Res 148 2008 94
7. D.J. Mountain, S.S. Kirkpatrick, M.B. Freeman, and et al. Role of MT1-MMP in estrogen-mediated cellular processes of intimal hyperplasia J Surg Res 173 2012 224
8. M.A. Tummers, D.J. Mountain, J.W. Mix, and et al. Serum levels of matrix metalloproteinase-2 as a marker of intimal hyperplasia J Surg Res 160 2010 9
9. D.J.H. Mountain, S.S. Kirkpatrick, S.L. Stevens, and et al. The role of urotensin II in estrogen-stimulated vascular smooth muscle cell proliferation and cytoskeletal reorganization Arterioscler Thromb Vasc Biol 2011 Abstract # P656
10. D. Grimm Small silencing RNAs: state-of-the-art Adv Drug Deliv Rev 61 2009 672
11. J. Wang, Z. Lu, M.G. Wientjes, and et al. Delivery of siRNA therapeutics: barriers and carriers Aaps J 12 2010 492
12. Y. Takahashi, M. Nishikawa, and Y. Takakura Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy Adv Drug Deliv Rev 61 2009 760
13. K.A. Whitehead, R. Langer, and D.G. Anderson Knocking down barriers: advances in siRNA delivery Nat Rev Drug Discov 8 2009 129
14. Y.C. Tseng, S. Mozumdar, and L. Huang Lipid-based systemic delivery of siRNA Adv Drug Deliv Rev 61 2009 721
15. J. Nguyen, and F.C. Szoka Nucleic acid delivery: the missing pieces of the puzzle? Acc Chem Res 45 2012 1153
16. G.T. Zugates, N.C. Tedford, A. Zumbuehl, and et al. Gene delivery properties of end-modified poly (β-amino ester)s Bioconjug Chem 18 2007 1887
17. D.M. Lynn, D.G. Anderson, D. Putnam, and et al. Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library J Am Chem Soc 123 2001 8155
18. J.J. Green, R. Langer, and D.G. Anderson A combinatorial polymer library approach yields insight into nonviral gene delivery Acc Chem Res 41 2008 749
19. U. Lächelt, and E. Wagner Invading target cells: multifunctional polymer conjugates as therapeutic nucleic acid carriers Front Chem Sci Eng 5 2011 275
20. B. Urban-Klein, S. Werth, S. Abuharbeid, and et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Gene Ther 12 2005 461
21. J.D. Arnold, D.J. Mountain, M.B. Freeman, and et al. Smooth muscle cell polymeric transfection is an efficient alternative to traditional methods of experimental gene therapy J Surg Res 177 2012 178
22. H.L. Che, I.H. Bae, K.S. Lim, and et al. Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model Biomaterials 33 2012 8548
23. G. Grassi, B. Scaggiante, B. Dapas, and et al. Therapeutic potential of nucleic acid-based drugs in coronary hyper-proliferative vascular diseases Curr Med Chem 20 2013 3515
24. S.M. Moghimi, P. Symonds, J.C. Murray, and et al. A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy Mol Ther 11 2005 990
25. H. Li, C.E. Nelson, B.C. Evans, and et al. Delivery of intracellular-acting biologics in pro-apoptotic therapies Curr Pharm Des 17 2011 293
26. F. Yang, S.W. Cho, S.M. Son, and et al. Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles Proc Natl Acad Sci USA 107 2010 3317